Novartis AG vs Block Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Block Inc trades at $80.35 (market cap $47.19B). The key difference: Novartis AG is far larger — about 6.2× Block Inc's market cap, and Novartis AG pays a 3.17% dividend while Block Inc pays none. Which is the better fit depends on your goals.
| NVS | XYZ | |
|---|---|---|
Market Cap | $290.25B | $47.19B |
Sector | Health | Technology |
52-Week High | $168.62 | $81.81 |
52-Week Low | $113.50 | $49.04 |
Enterprise Value | $330.27B | $42.06B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →